Glooko Insights
Stay up-to-date on our latest news and insights, enhancements to our connected care platforms, and Team Glooko happenings.
Glooko Expands EHR Integration Through Xealth: Diabetes Data, Embedded in the EHR
July 15, 2026For health systems that use Xealth to manage digital health applications, diabetes data integration no longer needs to be a tradeoff between workflow simplicity and clinical depth. By deploying Glooko’s diabetes management EHR integration capabilities through the Xealth platform, healthcare providers can bring rich diabetes data directly into EHR workflows while preserving the architecture and digital care strategy that care teams already trust. Many health systems rely on Xealth to prescribe, deliver and monitor digital health tools directly from the EHR, making it a central part of many digital care strategies. Xealth’s Digital Care SMART on FHIR capabilities allow clinicians to launch digital solutions from existing charting workflows, surface partner dashboards within the EHR, and return discrete patient data into the chart for easier review and follow-up care. By integrating Glooko’s diabetes management platform through Xealth, clinicians can remain in their familiar workflow while accessing Glooko diabetes reports, connected device data and discrete values that support efficient documentation, informed decision-making and more streamlined diabetes visits. Glooko Expanded EHR Capabilities Through the Xealth Platform Glooko EHR integrations through Xealth can now support the complete suite of core capabilities health systems look for in a diabetes data workflow: Glooko Patient Portal for Professionals: One-click access to the patient’s Glooko account from within the EHR window, reducing the need to switch platforms or leave the EHR.* PDF Report Integration: Attaches Glooko diabetes data to the patient’s EHR record. Flowsheet Statistics: Delivers discrete data including pump settings into the flowsheet of the EHR for easy documentation and analysis. Create Patient Account: Creates a patient account using data from the EHR. Single Sign-On: Secure, centralized access for professional admin users. Functional Parity Through Xealth A major advantage for health systems using Xealth is functional parity with Glooko’s broader EHR integration package. For organizations that rely on Xealth as their digital health orchestration layer, this means there is no need to compromise on integration depth. These health systems can simply extend existing Xealth environments with Glooko, gaining both a full visual report for clinical review and structured data that supports documentation, trending over time, and more robust clinical analysis. Better Workflow, Better Clinical Context This integrated approach streamlines day-to-day clinical workflows by reducing manual steps and making diabetes data easier to access at the point of care. Instead of printing, scanning and uploading diabetes reports for every visit, clinicians can receive Glooko PDF summaries automatically in the EHR, helping to eliminate a time-consuming process and free up time during visits. Unlocking More Efficient, Data-Driven Diabetes Care With Xealth and Glooko If your health system uses Xealth to manage digital health applications, Glooko can extend that investment with EHR-integrated diabetes data workflows that match the depth of a traditional integration approach. The result is a more efficient experience for care teams, richer clinical context inside the EHR, and a stronger path to scalable, data-driven diabetes care. To learn more, reach out to your dedicated Glooko Customer Success Manager or [email protected]. *One-click access to Glooko patient accounts from within the EHR is currently available for Epic only.
Learn more
The ROI of EHR-Integrated Diabetes Data
July 6, 2026Download the Case Study Now The Challenge: Manual Bottlenecks & Disconnected Data Managing a high volume of patients using hundreds of different diabetes devices created significant operational challenges for Michigan Medicine, including: 25-Minute Rooming Process: Hunting for device cords and logging into disparate platforms. Heavy Administrative Burden: Manually typing data from printed device reports into patient charts. High Risk & Costs: Increased risk of human error with manual data entry and massive paper waste (up to 100 pages per patient). The Solution: Seamless Epic® Integration via Glooko Michigan Medicine deployed Glooko’s device-agnostic platform directly inside their Epic® system, creating a unified, automated digital workflow with: One-Click Access: Direct access from the patient chart via Single Sign-On (SSO). Automated Data Flow: Instant delivery of PDF reports and flowsheet statistics upon device upload. Universal Compatibility: One secure platform supporting over 200 diabetes device brands. Inside the Case Study: Proven Results: Measurable ROI of improved efficiency, including $30K in direct cost savings annually and 91 full work days of clinical time reclaimed. Blueprint: How they mapped low-effort, high-impact EHR enhancements. Sustainability: Using “Centers of Truth” clinic hubs to onboard staff and mitigate turnover. Scale: Moving from reactive data chasing to proactive, data-driven diabetes care. Get the Case Study Now Discover how to eliminate administrative burden and reclaim clinical hours.
Learn more
Glooko Platform Adds Tandem Cloud Connectivity
June 29, 2026The Glooko diabetes management platform is now cloud-connected with Tandem insulin pumps, giving care teams automatic, continuous access to pump data without manual uploads, cables, or patient intervention. Once a patient links their Tandem Source account, data will synchronize automatically and continuously to the Glooko platform, ready for in-office visits and remote monitoring. This integration reflects our ongoing commitment to ensure that wherever a patient’s data lives — whichever device they wear, whichever platform stores it — that data flows seamlessly into the platform their care team relies on. Expanding cloud connectivity is central to our mission of bridging the gap between people living with diabetes and their healthcare providers. Why Cloud-to-Cloud Integration Matters For people living with diabetes who use an insulin pump, data is only useful if their care team can access it efficiently. Until now, that often meant asking patients to remember to upload their device data before an appointment, or handling that step in the clinic—an extra task that slows down the visit and, in some cases, means arriving without the data at all. A direct cloud connection eliminates that friction. The Tandem mobile apps upload pump data to the Tandem Source platform approximately once per hour. With this new integration, that data—including basal and bolus deliveries, glucose trends, pump status, alerts and alarms—flows automatically into the Glooko platform without cables or manual steps. What Automatic Sync Delivers The core value of this integration is time: time recovered in the exam room, time saved across a busy clinic schedule, and more time for the conversations that matter between a person living with diabetes and their care team. Key benefits of automatic sync include: Continuous data availability. Pump data updates to the Glooko platform approximately every hour, so the record stays current between appointments. No patient action required after setup. Once accounts are linked, synchronization happens in the background. Complete therapy picture. Basal rates, bolus events, glucose trends, and device alerts are all captured in a single view for a more complete therapeutic picture. Consistent data for remote monitoring. Care teams using Glooko’s remote patient monitoring (RPM) workflows can track t:slim X2 insulin pump and Tandem Mobi* system users without waiting for an in-person visit enabling timely, proactive care from anywhere. Streamlined Workflows for Diabetes Care For care teams managing insulin pump users, pre-populated data before the patient arrives changes an appointment. Clinicians can review recent trends, flag periods of hyperglycemia or hypoglycemia, work on pre-charting, and formulate questions before the patient walks through the door. Glooko’s clinic dashboard surfaces population-level insights alongside individual patient records. With TIDE metrics and CGM Patient Risk Stratification built into the platform, care teams can prioritize outreach to patients who need it most, including those using the t:slim X2 pump or Tandem Mobi, whose automated insulin delivery data is now part of the same integrated view. For clinics using EHR integrations, Tandem pump data joined to the Glooko record is accessible across platforms including Epic, Oracle Health, MEDITECH, Greenway Health, eClinicalWorks, NextGen, and Athenahealth. This ensures documentation is in sync without the need for duplicate entries. Completing Connectivity Across Advanced Device Therapy The Glooko platform is now cloud-connected to the major manufacturers whose devices define advanced diabetes therapy for most people on CGMs and insulin pumps today: Abbott (FreeStyle Libre), Dexcom (G6 and G7), Insulet (Omnipod 5), and now Tandem (t:slim X2 and Tandem Mobi). Together, these four platforms cover the dominant CGM systems and the insulin delivery systems for people on hybrid closed loop and advanced therapy. Now the vast majority of people living with diabetes on advanced device therapy can have their data flow automatically into their care team’s workflow, without manual steps and without relying on manual uploads. Getting Started with the Tandem Cloud Connection Setting up the Tandem cloud connection requires a one-time account-linking step from the patient side. Once complete, data synchronization begins automatically and continues without additional steps. For step-by-step setup instructions, visit our Support Center. *The Tandem Mobi system is not available in all regions.
Learn more
Glooko Web 26.2 and Mobile 6.16 Release Brings Pump Settings Into the EHR and Adds Smarter Patient Context
June 16, 2026We are excited to share the latest updates included in Glooko Web 26.2 and Glooko Mobile 6.16. This release is designed to help care teams reduce documentation burden, surface richer patient context at the point of care, and support more efficient diabetes management workflows across the Glooko platform.
Learn more
How We Are Speeding Up Glooko to Better Serve People with Diabetes and Care Teams
May 19, 2026Glooko CTO Prakash Menon shares how we optimized our connected care solutions for healthcare providers and people with diabetes to be faster and more reliable.
Learn more
Advancing Connected Diabetes Management with mylife Diabetes Care
May 12, 2026Glooko’s Dave Conn shares the benefits of Glooko serving as the primary data management provider for mylife products.
Learn more
More Seamless Diabetes and Health Data Tracking in the Refreshed Glooko Mobile App Experience
March 13, 2026The refreshed Glooko Mobile App experience, designed for the busy days of people living with diabetes, makes tracking diabetes and health data easier.
Learn more
Closing the Care Gap: Unifying Inpatient Precision and Outpatient Insight to Help Prevent Cardiovascular Events
February 23, 2026For American Hearth Month, Glooko shares how the diabetes and glycemic management company’s digital health solutions could help prevent cardiovascular events.
Learn more
The Future of Diabetes Care and Glycemic Management: Outlook and Predictions for 2026
February 6, 2026Glooko experts provide strategic predictions and their 2026 outlook for the evolution of diabetes care and glycemic management.
Learn more
Glooko Web 25.4 and Mobile 6.14 Release Enhances Clinic Dashboard, Introduces Direct Epic Access, and Simplifies Device Management
January 28, 2026Glooko Web 25.4 and Mobile 6.14 features an enhanced clinic dashboard that displays within the Epic EHR and easier management of diabetes devices and apps.
Learn more
Looking Back on a Defining Year for Glooko, and Ahead to What’s Next for Diabetes Innovation
December 23, 2025Glooko CEO Mike Alvarez explores the global diabetes management company's 2025 milestones and looks ahead to what's next for diabetes innovation in 2026.
Learn more
Introducing the Redesigned Glooko Food Tracking Experience: Smarter, Faster, More Insightful
December 10, 2025The Glooko Mobile App features redesigned food tracking for faster, more insightful meal logging, simplifying diabetes management for patients and care teams.
Learn more
Go Beyond Glucose: Easily Sync Fitness and Health Data with Glooko for Better Diabetes Management
October 6, 2025The Glooko Mobile App easily tracks and syncs fitness, health, and diabetes data for greater insights, enhanced diabetes management, and more personalized care.
Learn more
From Hospital to Home: How Glooko’s New Acquisition Connects Diabetes Care
September 23, 2025Today marks an important milestone in our mission to transform diabetes care. I am excited to share that Glooko has acquired Monarch Medical Technologies, creators of the EndoTool® Glucose Management System. With this acquisition, Glooko is positioned to become the only diabetes management company with the potential to connect the full continuum of care — from home to hospital and back again. By bringing together EndoTool’s proven inpatient insulin dosing technology with Glooko’s leading outpatient platform, we aim to create a future where care is seamless, safer, and more supportive for both people living with diabetes and healthcare providers. For patients, this means fewer disruptions as they move between settings, reduced risk of dangerous glycemic events, and more confidence that their care is connected. For healthcare providers, it means access to tools that simplify complex insulin management, standardize protocols, and free up time to focus on what matters most, which is caring for people. This step also sets the foundation for Glooko’s future: using data and AI to help clinicians anticipate risks earlier, personalize care at scale, and improve outcomes under value-based models. By aligning advanced technology with clinical guidelines and EHR workflows, we can help hospitals and health systems deliver higher-quality care while lowering costs. Our mission has always been clear: to simplify diabetes management, strengthen connections across the care team, and improve lives. This acquisition represents an important stride toward that vision. Together, we are building a future where diabetes care is more connected, proactive, and patient-centered than ever. EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions.
Learn more
New Glooko Web 25.2 and Mobile 6.12 Release Introduces New Clinic Dashboard and Updated Tools to Enhance Diabetes Management
September 9, 2025Glooko Web 25.2 and Mobile 6.12 features a new clinic dashboard for healthcare providers of people living with diabetes and other helpful enhancements.
Learn more
How Glooko Advances Diabetes Care and Management in the NHS 10 Year Health Plan
August 25, 2025Glooko aligns with the NHS's 10 Year Health Plan by driving digital transformation, enabling remote care, and fostering prevention for better diabetes outcomes.
Learn more
Complexity to Clarity: How Glooko’s Device Integrations Simplify Diabetes Care
August 7, 2025Managing diabetes care has become increasingly complex for clinics, hospitals, and health systems. With a growing number of people living with diabetes relying on multiple devices — glucose meters, continuous glucose monitors (CGMs), insulin pumps, and wearables — healthcare providers face the challenge of piecing together critical data from siloed systems. This fragmentation not only consumes valuable time, but hinders patient care. At Glooko, we know device integration is the key to solving these challenges and transforming diabetes management. As a market leader in device compatibility, EHR integration, and interoperability, Glooko increases efficiency of clinical workflows by streamlining administrative tasks, enhances patient engagement, and helps deliver better outcomes. The Challenges of Fragmented Diabetes Management For healthcare providers, piecing together data from various devices and platforms and apps can feel like an endless puzzle. Without device integrations, clinics and health systems face: Disconnected Data: Patient data is scattered across incompatible platforms and apps, making it difficult to understand a patient’s holistic health. Inefficient Workflows: Healthcare providers must spend time manually entering or retrieving data instead of focusing their time and expertise to support their patients in achieving better health. Limited Patient Engagement: Patients often struggle to track their progress with so many different tools and apps, becoming overwhelmed and losing hope in their ability to make meaningful change. These challenges contribute to missed opportunities for timely interventions that drive better health outcomes. How Glooko’s Compatibility Brings Clarity to Diabetes Care Glooko simplifies diabetes management by integrating data from more than 200 diabetes and health monitoring devices — including Abbott’s FreeStyle Libre CGMs in the U.S. — into a single, user-friendly platform. Here’s how Glooko’s device compatibility transforms care: Data Integration and Interoperability: Glooko consolidates glucose levels, insulin usage, and lifestyle behaviors such as diet and physical activity, giving healthcare providers a holistic view of patient health. Care teams can easily access patient data from a centralized platform. Remote Monitoring Capabilities: Healthcare providers can track patient trends and progress between visits, ensuring timely adjustments to care plans and reducing unnecessary appointments and emergency room visits. Not all devices are available in every country where Glooko is available. The product images are for illustrative purposes only. Not actual patient data. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission. Important Safety Information: For full FreeStyle Libre systems safety information, please visit https://www.freestyle.abbott/us-en/safety-information.html. The Many Benefits of Integration for Clinics, Hospitals, and Health Systems Our industry-leading device compatibility benefits clinics, hospitals, and health systems by streamlining workflows and improving decision-making through a comprehensive view of patient data. With greater efficiency, care teams can focus more on patient care and expand their reach to serve more individuals in need. Streamlined Workflows: Staff spend less time on administrative tasks and more time on what they do best: educating and providing care to their patients. Improved Decision-Making: A comprehensive view of patient data allows care teams to create more personalized and effective treatment plans. Expanded Clinical Footprint: With more time, clinicians can help more patients in need. To enable more meaningful data insights, Glooko also seamlessly integrates the health data from their patients’ diabetes and health monitoring devices directly into leading EHR systems, eliminating manual uploads and platform switching and reducing administrative burden. The Key Benefits of Device Integrations for People Living with Diabetes Glooko’s device integrations benefit people living with diabetes by simplifying their experience and empowering self-management through centralized data, reducing app overload and supporting informed health decisions. Simplified Experience: With integrated data, patients no longer need to juggle multiple apps and passwords, or manually report their glucose levels to their provider. Empowered Self-Management: Patients can log meals, exercise, and medications directly in the Glooko app, helping them understand how their choices impact their health. Proven Results Backed by Global Expertise Glooko has more than a decade of experience integrating diabetes and health monitoring devices worldwide, supporting millions of people living with diabetes. Glooko’s connected care platform, backed by real-world evidence, delivers the reliability, scalability, and insights clinics, hospitals, and health systems need to stay ahead in diabetes care, setting a new standard. Simplify Diabetes Care with Glooko The complexity of diabetes management doesn’t have to hold your clinic, hospital, or health system back. By choosing Glooko, you can eliminate data fragmentation, enhance patient care, and create a more efficient, streamlined experience for healthcare providers and people living with diabetes. Schedule a personalized demo of our digital health platform today and see how your patients’ health data can be integrated directly into your EHR system.
Learn more
Optimizing Diabetes Management with Glooko and Hybrid Closed Loop Systems
July 30, 2025As a leader in diabetes management, Glooko offers an intelligent connected care platform that allow people with diabetes and their healthcare providers to review, analyze, and evaluate data from many different types of diabetes devices, including blood glucose meters (BGM), continuous glucose monitoring (CGM) systems, insulin pumps, smart pens, and fitness apps. With Glooko’s digital health solution allowing users to view and analyze CGM and insulin data in one place, we have the ability to work with hybrid closed loop systems, a technology — often known as an artificial pancreas — that automates many of the daily decisions of people living with Type 1 diabetes who use an insulin pump and CGM that communicate with each other. Innovative hybrid closed loop systems take readings from an individual’s CGM and use an algorithm to automatically tell the insulin pump how much insulin to deliver to keep blood glucose levels stable around the clock. How Glooko integrates with hybrid closed loop systems Our digital health platform, used by over 10,000 clinics in more than 30 countries, syncs via the cloud with leading diabetes CGMs and insulin pumps in hybrid closed loop systems to automatically present data around glucose levels, basal rates and more to patients and their care teams via graphically-oriented reports that can help recognize trends, so they can take action to improve their health outcomes. The hybrid closed loop systems that currently sync with Glooko include: mylife Loop (CamAPS FX and Ypsomed) Tandem Control-IQ Insulet Omnipod 5 Dana CamAPS® FX Depending on the brands of the insulin pump and CGM, different methods of syncing via cloud are required to view data in Glooko from hybrid closed loop systems. Method 1 Method 2 Like any great technology, people living with diabetes using a closed loop system still must check to ensure it is working and must count carbohydrates to give the system the correct bolusing data before food consumption. This is where the Glooko Mobile App’s food tracker can be used to track nutrition by searching the food database, using voice capture, or scanning a barcode (in select countries). Benefits of using hybrid closed loop systems with Glooko There are many benefits of using hybrid closed loop systems alongside Glooko for patients, including: Major changes in treatment that reduce daily burdens and mental stress More time with glucose levels in range with less effort The ability to visualize blood glucose and insulin data in clear graphs that make it easier to understand automatic boluses and basal rates There are also many benefits of using hybrid closed loop systems alongside Glooko for care teams, including: An increased monitoring of patients with diabetes who are using closed loop systems Strengthening their connection with their patients Better management of fluctuations in patients’ glucose levels Easier interpretation of patient data around basal rate, automatic vs. manual mode and automatic boluses The future of hybrid closed loop systems Hybrid closed loop systems in diabetes care are advancing toward more automation, intelligence, and accessibility. These systems are on a path toward becoming fully closed loop systems that will make managing diabetes more automated, adaptive, and accessible, allowing users to focus less on their condition and more on living life. As the systems evolve, so will Glooko. With the regular introduction of new hybrid closed loop systems, Glooko will continue to partner with leading device manufacturers to integrate their platforms with our digital health solution. For more information about using a hybrid closed loop system, consult with your healthcare team and explore resources from the Breakthrough T1D, Diabetes UK, and NHS England.
Learn more
2025 Global Diabetes Report: Transforming Diabetes Management with Thorough Actionable Insights
June 20, 2025Glooko's 2025 Global Diabetes Report reveals trends in glycemic management, tech use, and behaviors, showing how real-world data improves diabetes care.
Learn more
Transforming Diabetes Management: A Step Forward with Abbott’s FreeStyle Libre CGMs and Glooko
June 18, 2025At Glooko, we are committed to simplifying diabetes insights and management for people living with diabetes and healthcare providers alike. That’s why our platform is compatible with more than 200 diabetes and health monitoring devices and growing. As a company, we could not be more pleased to share that we recently expanded our capabilities to integrate with Abbott’s FreeStyle Libre CGMs in the United States. This integration brings glucose data to more clinics and health systems in our all-in-one solution for diabetes management. This milestone is more than just a technological advancement — it’s about empowering people with Type 1, Type 2, and gestational diabetes, as well as prediabetes, to become active owners in their health. By combining the precision of Abbott’s FreeStyle Libre CGMs with Glooko’s comprehensive platform, we can provide people living with diabetes and their care teams, including endocrinologists and nurses, with a unified, holistic view of diabetes management and irrefutable information. From glucose trends to lifestyle behaviors like diet and physical activity, this latest integration ensures that critical insights are easily accessible when and where they are needed most. For healthcare providers and health systems, this means the ability to seamlessly access and analyze patients’ CGM data through Glooko and established electronic health record (EHR) solutions, more informed decision-making, and improved patient outcomes. For people living with diabetes, it means greater confidence in their care and health. As the number of people with diabetes continues to grow, the need for seamless, data-driven solutions has never been greater. Our new integration with Abbott’s FreeStyle Libre CGMs represents a significant step forward in delivering better, more connected care. This partnership is sure to have a positive impact on the millions of people who rely on FreeStyle Libre CGMs and Glooko.
Learn more